Will This be the Tipping Point for Telemedicine in the U.S.?

While it remains to be seen what the telemedicine regulatory landscape will look like post-pandemic, telemedicine visits as a fraction of total doctor visits spiked in Q2 2020, and remain at an elevated level from the start of the year.

Telehealth, in particular, can lower costs and broaden access to care. In the last decade, companies like Livongo (chronic disease management) and PillPack (an online pharmacy) emerged to help seniors better access healthcare.

A point I’ve tried to hammer home is that tech in healthcare is only useful if enables a new workflow and as a result can change the economics of that process. For example, face-to-face telemedicine isn’t interesting because it’s the same workflow as an office visit, but asynchronous telemedicine lets you interact with many more patients and drop t... See more